On Thursday, Gilead Sciences (NASDAQ: GILD) said it has appointed Sanofi’s (NASDAQ: SNY) Dietmar Berger as its chief medical officer, […]
Gilead Appoints Sanofi Official Dietmar Berger as Next Chief Medical Officer Read More »
SHANGHAI – Sanofi (NASDAQ: SNY) plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production
Sanofi Announces its Biggest China Investment Deal Amid EU-China Trade Tensions Read More »
Sanofi (NASDAQ: SNY), the French drugmaker, plans to change its policy on how it gives discounts to certain U.S. hospitals
Sanofi to Revise US Hospital Drug Discount Program, WSJ Reports Read More »
On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third
Sanofi (NASDAQ: SNY) Posts Q3 Profit Beat on Early Start of Vaccine Sales Read More »
LONDON – Buyout fund CD&R’s keenly awaited 16 billion euro ($17.36 billion) deal to take control of Sanofi’s (NASDAQ: SNY)
Analysis: Dealmakers Expect Bigger European Private Equity Buyouts and More of Them Read More »
PARIS – Sanofi (NASDAQ: SNY) agreed on terms to sell a controlling stake in its consumer health unit Opella to
Sanofi Agrees to Sale Terms for Consumer Health Unit, Say French Government Sources Read More »
PARIS – On Monday, Sanofi (NASDAQ: SNY), the French drugmaker, said it had entered exclusive talks to sell a 50%
Sanofi (NASDAQ: SNY) in Exclusive Talks with CD&R to Sell Consumer Health Unit Opella Read More »
PARIS – On Thursday, Sanofi (NASDAQ: SNY), the French drugmaker, said it was “surprised” by a renewed, higher offer for
Sanofi “Surprised” as PAI Partners Raises Bid for Opella Unit Read More »
PARIS – The French government needs guarantees from drugmaker Sanofi (NASDAQ: SNY) that production of its popular Doliprane painkiller will
France Seeks Job Guarantees from Sanofi Over Doliprane Painkiller Production Read More »
Copyright © 2024 abbonews.com
